The route back to 25 by 25

Prior to the pandemic, real progress was being made in raising five-year lung cancer survival rates in the UK. However, COVID-19 has had a devastating impact on early diagnosis of lung cancer and has put the UKLCC’s target of driving up the five-year UK survival to 25 percent by 2025 (25 by 25) in jeopardy.

This report provides a blueprint for politicians and policymakers setting out the most important areas of focus to improve lung cancer outcomes. This is focused on solutions which the clinical community believe will have the biggest impact on outcomes. We need to act collectively and urgently to rebuild and recover from the consequences of the pandemic on lung cancer and get back on track to deliver a step change in lung cancer outcomes.